RYLPF
Koninklijke Philips N.V. OTC$25.51
Mkt Cap $24.3B
52w Low $22.28
30.1% of range
52w High $33.00
50d MA $28.79
200d MA $28.05
P/E (TTM)
29.5x
EV/EBITDA
10.0x
P/B
2.4x
Debt/Equity
0.7x
ROE
8.2%
P/FCF
23.5x
RSI (14)
—
ATR (14)
—
Beta
0.96
50d MA
$28.79
200d MA
$28.05
Avg Volume
234
About
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutio…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | AMC | 0.56 | 0.70 | +25.0% | 33.00 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Nov 4, 2025 | AMC | 0.37 | 0.22 | -38.8% | 27.65 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jul 29, 2025 | AMC | 0.32 | 0.30 | -6.6% | 28.00 | +0.0% | +0.0% | +0.0% | +0.0% | -5.4% | -5.4% | — |
| May 6, 2025 | AMC | 0.21 | 0.08 | -60.8% | 25.45 | +0.0% | +0.0% | -3.6% | -3.6% | -2.4% | -2.4% | — |
| Feb 19, 2025 | AMC | — | -0.37 | — | 24.56 | +0.1% | +0.8% | +5.0% | +4.0% | +6.3% | +6.3% | — |
| Oct 28, 2024 | AMC | 0.43 | 0.21 | -50.9% | 25.58 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jul 29, 2024 | AMC | — | 0.54 | — | 25.96 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Apr 29, 2024 | AMC | 0.29 | -1.15 | -496.8% | 27.13 | -1.5% | -1.5% | -1.5% | -0.6% | -2.9% | -0.8% | — |
| Mar 12, 2024 | AMC | 0.56 | 0.05 | -91.8% | 21.33 | +0.0% | +0.0% | +0.0% | -0.3% | -3.0% | -3.0% | — |
| Sep 30, 2023 | AMC | 0.30 | 0.10 | -66.8% | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24 | Societe Generale | Downgrade | Buy → Hold | — | — | — | — | — | — | — | — | — |
| Jan 19 | Jefferies | Downgrade | Buy → Hold | — | $33.82 | $34.18 | +1.1% | +1.1% | +1.2% | -1.6% | -6.5% | -2.1% |
| Jan 13 | HSBC | Upgrade | Hold → Buy | — | $32.57 | $33.16 | +1.8% | +6.3% | +4.9% | +3.8% | +4.9% | +5.1% |
| Jan 11 | Citigroup | Downgrade | Buy → Neutral | — | $37.79 | $38.39 | +1.6% | +1.6% | -13.8% | -8.4% | -9.6% | -10.5% |
| Jul 7 | Deutsche Bank | Downgrade | Buy → Hold | — | $48.27 | $47.34 | -1.9% | -0.8% | -3.1% | -3.2% | -1.6% | -2.3% |
| Mar 17 | JP Morgan | Upgrade | Neutral → Overweight | — | $56.40 | $57.29 | +1.6% | +0.9% | +0.9% | +1.0% | +1.8% | +1.7% |
| Jan 12 | BofA Securities | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Dec 5 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $45.40 | $45.40 | +0.0% | +0.0% | +0.0% | +0.0% | +4.6% | +3.7% |
| Oct 15 | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | — | — | — | — | — | — | — | — |
| Jun 20 | Natixis | Downgrade | Buy → Neutral | — | $37.66 | $37.66 | +0.0% | +0.0% | -2.7% | -2.7% | -2.7% | -2.5% |
Data updated apr 27, 2026 7:58pm
· Source: massive.com